Alzheimer's Immune Therapy Shows Positive Early Trial Results
An immune-based therapy designed to treat Alzheimer's disease has demonstrated encouraging outcomes in its initial Phase I clinical trial. These early findings represent a significant step forward in the ongoing search for effective treatments for the neurodegenerative condition.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.